ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Mitigating the Adverse Impact of Broader Kidney Sharing with Hospital-based Machine Perfusion

    Y. Yushkov, B. R. Schleich, T. Carrea, V. Wadhera, M. J. Goldstein

    Hackensack University Medical Center, Hackensack, NJ

    *Purpose: The new UNOS kidney allocation changes effective December 2020 will be removing the geographic limits of donation service areas (DSA) and UNOS regions favoring…
  • 2021 American Transplant Congress

    AM PAC Scores and Liver Transplant Resource Utilization

    M. Pierpont1, M. Gosselin2, K. Robichaux3, A. Kumar1, J. Buggs4, N. Kemmer5

    1Morsani College of Medicine, University of South Florida, Tampa, FL, 2Honors College, University of Tampa, Tampa, FL, 3Honors College, University of South Florida, Tampa, FL, 4Transplant Surgery, Tampa General Hospital, Tampa, FL, 5Transplant Hepatology, Tampa General Hospital, Tampa, FL

    *Purpose: Activity Measure for Post-Acute Care (AM-PAC) is a tool utilized to assess three functional domains: basic mobility, daily activities, and applied cognition. Previous studies…
  • 2021 American Transplant Congress

    Benign Pneumatosis Intestinalis with Pneumoperitoneum in the Immunocompromised Patient: Three Cases

    A. Mohamed, K. Delvecchio, T. Kitajima, M. Rizzari, K. Collins, A. Yoshida, S. Nagai, J. Denny, M. Abouljoud

    Department of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI

    *Purpose: Isolated pneumatosis intestinalis after solid organ transplantation, as well as its surgical management in appropriate clinical context, is a well described entity. The management…
  • 2021 American Transplant Congress

    TPIAT Outcomes in Diabetic and Non-diabetic Patients

    M. A. Kanak, J. B. Spriggs, P. Coughenour, J. Kalivarathan, P. Saravanan, M. Levy

    Virginia Commonwealth University, Richmond, VA

    *Purpose: Total pancreatectomy with islet auto-transplant (TPIAT) has become a mainstay treatment for patients who suffer from refractory chronic pancreatitis. It has consistently been shown…
  • 2021 American Transplant Congress

    Achilles Heel No Longer: Marked Decline in Early Relaparotomy and Allograft Pancreatectomy Rates Following Simultaneous Kidney-Pancreas Transplantation in the Contemporary Era

    B. Sharda1, K. Gurung2, R. Stratta2, A. Farney2, G. Orlando2, C. Jay2, A. Reeves-Daniel3, A. Mena-Gutierrez3, N. Sakhovskaya3, W. Doares4, S. Kaczmorski4, M. Magid4, J. Rogers2

    1Wake Forest Baptist Medical Center, Winston Salem, NC, 2Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, 3Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, 4Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC

    *Purpose: Technical complications requiring early relaparotomy (relap) and allograft pancreatectomy (AP) have long been the Achilles heel of simultaneous kidney-pancreas transplantation (SKPT).*Methods: Single center retrospective…
  • 2021 American Transplant Congress

    The Quality Incentive Program (QIP) is Associated with Increased Waitlisting for Transplantation

    J. T. Adler1, L. Xiang1, J. S. Weissman1, J. R. Rodrigue2, R. E. Patzer3, S. S. Waikar4, T. C. Tsai1

    1Surgery, Brigham and Women's Hospital, Boston, MA, 2Surgery, Beth Israel Deaconess Medical Center, Boston, MA, 3Surgery, Emory University, Atlanta, GA, 4Surgery, Boston Medical Center, Boston, MA

    *Purpose: The Centers for Medicare & Medicaid Services (CMS) introduced the Quality Incentive Program (QIP) in 2012, a pay-for-performance program which penalizes dialysis centers payments…
  • 2021 American Transplant Congress

    Has the Proportional Rise in Deceased Organ Donation Rate Over Last 5 Years Been Optimal? Data-based, Forecasting Model Analysis of UNOS/NHSBT UK Donor Data

    H. Sharma1, A. Sharma2

    1Transplant and Vascular Access Surgery, Royal Liverpool University Hospital, Liverpool, United Kingdom, 2Data Analytics, Loyola University, Chicago, IL

    *Purpose: The increase in deceased donor numbers since last decade has been widely reported. We aim to analyse if the trend in rise of numbers…
  • 2021 American Transplant Congress

    Short Term Outcomes in Previously Covid Positive Living Kidney Donors and Their Recipients

    R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Study short term outcomes of living kidney donors (LKD) who were previously infected with COVID 19, and in their recipients.*Methods: After a brief hiatus…
  • 2021 American Transplant Congress

    Combined CD11b/CD40 Blockade is Superior to CD40 Blockade Alone in Prolonging Survival in Pig-to-Nonhuman Primate Renal Xenotransplantation

    D. A. Faber1, B. Lovasik1, A. Matar1, C. Breeden1, S. Kim1, A. Adams2

    1Surgery, Emory University School of Medicine, Atlanta, GA, 2Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: Blockade of the CD40/CD154 pathway is highly effective in preventing rejection in pig-to-nonhuman primate (NHP) xenotransplantation models. Clinical translation of anti-CD154 mAbs, however, has…
  • 2021 American Transplant Congress

    Peripheral Blood Hematopoietic Chimerism: A Robust Biomarker for Transplantation Tolerance

    D. Tollerud1, E. Gornstein1, J. Leventhal2, K. V. Ravindra3, S. Ildstad1

    1Talaris Therapeutics, Louisville, KY, 2Division of Organ Transplantation, Northwestern Medical Group, Chicago, IL, 3Department of Surgery, Duke University Medical Center, Durham, NC

    *Purpose: Despite the development of highly effective immunosuppressive medications, organ rejection and the toxicity of the drugs themselves remain significant obstacles to long-term graft and…
  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences